Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006
about
The emerging epidemic of endometrial cancer: Time to take actionAdjuvant chemotherapy for advanced endometrial cancerSurgery and chemotherapy with or without radiotherapy for disseminated advanced endometrial cancerHysterectomy in very obese and morbidly obese patients: a systematic review with cumulative analysis of comparative studiesEstrogen receptor β: the guardian of the endometriumTelmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cellsEpithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Discovery and validation of methylation markers for endometrial cancer.Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinomaDeregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinomaNationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.Brain metastases from endometrial carcinoma.Trends in the demographic and clinicopathological characteristics in Japanese patients with endometrial cancer, 1990-2010.Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parametersIncidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980-2013): an analysis of population-based data in relation to socioeconomic changes.Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer.Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer.Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to MenopauseRisk of uterine cancer in symptomatic women in primary care: case-control study using electronic records.Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?Features of omental adipose tissue in endometrial cancer patients with 'standard' or 'metabolically healthy' obesity: associations with tumor process characteristics.Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesityThe levels of the sex hormones are not different between type 1 and type 2 endometrial cancer.Use of mutation profiles to refine the classification of endometrial carcinomas.Bevacizumab in endometrial cancer treatment.Obesity and Endometrial Cancer.Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano.N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer.Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.Cancer incidence in Canada: trends and projections (1983–2032).The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.Endometrial cancer evolution: new molecular-biologic types and hormonal-metabolic shifts.Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues.Cancer endocrinology through own experience: areas for further thought and development. Interview by Natasha Galukande.Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears.Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.
P2860
Q24187085-83391647-2768-4A4C-A545-C568A2C945F6Q24194639-09F290BB-41FD-4E06-AE77-ABB13DB04134Q24200683-D2625A22-24D9-4BD9-9880-678B5E0860FFQ26998724-BD8BD4FC-E04F-4648-9B96-D28817AF5521Q28249571-592FD089-4255-444F-827A-9DFEF9EBDB3CQ28541515-4295B0FB-AE8B-43A0-AFF6-A2C388453BEEQ33872622-BFC0C897-7639-4710-B7E8-F69016826EEDQ34020931-5F42FA1E-AB21-41EA-A0D8-1089BCF259BDQ34362064-4FCC004A-EAEA-4C24-84AD-39983A6FB930Q34393036-4EB70777-DEC7-49ED-B77D-2024F1AB28BAQ34516506-C8C04FDC-3CA6-4875-8F83-B046DB9EA37AQ35609995-106F3FDE-8B7A-4A05-98CF-8F1875BEFCE8Q35864062-A36BF8A9-BAF4-4E71-8F83-73C43943BBCFQ36008845-6066C813-7ABE-4ACE-AEFF-5C4E98EBFF72Q36027067-18E16CFE-9765-4C9E-BC9A-30AE81CE918EQ36142237-2DE9A17E-0C40-4F01-9B4B-3CD68F593315Q36187512-9E80BA44-C305-4B98-B659-7526B0EECDE3Q36190111-EEA8BAF9-B9BF-4B0A-9BB8-2655BAB35FD1Q36356015-49BD4F72-AE8B-4C3D-BC1E-068C671E5AF8Q36579733-A038A4E5-C7BA-40CA-9224-D5ABDF14FB64Q36878675-B331A3E8-1C2F-48E9-8C50-478C31221899Q37015755-F46201EC-7EC9-47C4-B078-D24AA1B5C9A2Q37114149-DF135E5F-0BFA-4096-BEB6-C0CCC9E68A78Q37214295-D66CF5AB-AFFF-49C1-839E-FCD2F8721100Q37382304-29A99E35-44D3-4A5B-8B04-C602C1736DA5Q37474382-3B3239EA-398C-4A88-A0E5-175577487AC1Q37522285-57D8F45F-9BE3-4472-9495-8B3A0636B6E0Q37612253-56CA0A25-2673-4D0F-8032-A3EA870EC8D5Q37994752-E9656747-FDD6-43F0-9AC1-275A72946435Q39026659-1D7B90A2-D898-4371-A01D-14E240AA52FCQ39131438-2AC87A51-59CC-47A5-B24D-4A5B3EB5D616Q39335108-D879B566-A982-46DD-A9E9-B2F32F5CB7A1Q44132305-CC8296F8-385D-4E44-A60C-7944DC1F1E21Q46495297-50AD01A3-11E9-4DCC-BF3D-138A71CFFF74Q47160948-7828C17B-22AA-4BD4-9EF9-59B9ECC8C188Q47424270-8CE3F230-BA83-4B6C-867C-27FD11A41BF3Q48074431-510F8497-0C6A-4EC1-95CA-345F7DD93DDEQ48210184-4C36622B-4302-489F-AE0D-3F4CB709089CQ48296316-14E89DB5-0DE7-40D1-A800-C05F96CBB31CQ50219093-9C619588-0152-42C9-9536-2565B3E16D8B
P2860
Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Differential trends in the ris ...... sed registry from 1994 to 2006
@ast
Differential trends in the ris ...... sed registry from 1994 to 2006
@en
type
label
Differential trends in the ris ...... sed registry from 1994 to 2006
@ast
Differential trends in the ris ...... sed registry from 1994 to 2006
@en
prefLabel
Differential trends in the ris ...... sed registry from 1994 to 2006
@ast
Differential trends in the ris ...... sed registry from 1994 to 2006
@en
P2093
P2860
P356
P1476
Differential trends in the ris ...... sed registry from 1994 to 2006
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.68
P407
P50
P577
2011-04-01T00:00:00Z
P5875
P6179
1006475926